90
Participants
Start Date
April 30, 2005
Primary Completion Date
December 31, 2005
Study Completion Date
December 31, 2005
ezetimibe (+) simvastatin
Patients will receive the combination of ezetimibe/simvastatin 10/20 mg o.d. with the possibility to increase the dose to 10/40 mg o.d. for 1 year. Tablets
simvastatin
Patients will receive 40mg od. With the possibility to escalate the dose to 80 mg o.d. if therapeutic goals not attained; for 1 year. Tablets
pravastatin
Patients will receive pravastatin 40 mg o.d. with the possibility to add up 10mg of ezetimibe daily if LDL-C goal is not achieved; for 1 year. Tablets
Merck Sharp & Dohme LLC
INDUSTRY
Hospital Universitario 12 de Octubre
OTHER